Sanctuary Advisors LLC Sells 397 Shares of Encompass Health Co. (NYSE:EHC)

Sanctuary Advisors LLC cut its holdings in shares of Encompass Health Co. (NYSE:EHC) by 2.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,228 shares of the company’s stock after selling 397 shares during the quarter. Sanctuary Advisors LLC’s holdings in Encompass Health were worth $1,499,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. State Street Corp raised its holdings in Encompass Health by 0.7% during the third quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after acquiring an additional 21,329 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after purchasing an additional 20,547 shares in the last quarter. Copeland Capital Management LLC boosted its holdings in shares of Encompass Health by 0.7% in the 4th quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock valued at $119,418,000 after buying an additional 8,548 shares during the last quarter. Point72 Asset Management L.P. grew its stake in shares of Encompass Health by 2,458.5% in the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after buying an additional 835,135 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its holdings in Encompass Health by 0.4% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 769,716 shares of the company’s stock worth $71,083,000 after buying an additional 2,904 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Barclays lifted their price target on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Truist Financial reiterated a “buy” rating and set a $116.00 target price (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Finally, StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Ten research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $107.67.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.10% of the stock is currently owned by company insiders.

Encompass Health Stock Performance

EHC opened at $98.86 on Tuesday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The business has a fifty day simple moving average of $96.01 and a 200 day simple moving average of $96.05. Encompass Health Co. has a 1 year low of $73.68 and a 1 year high of $104.55. The company has a market capitalization of $9.96 billion, a PE ratio of 22.17, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Research analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. The ex-dividend date is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.